Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
By CNBC | 1 min read
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
# Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug. **Read the full article:** [CNBC](https://www.cnbc.com/2026/04/07/novo-nordisks-wegovy-pill-launch-draws-new-wave-of-patients-to-glp-1s.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*